Lifecore Biomedical Inc

LFCR | $7.07 -1.12% -1.13% 86K

(0.0% 1d) (0.0% 1m) (-10.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (19.49% volume)
Earnings Calendar: 2023-10-05
Market Cap: $ 214,377,735
https://www.landec.com
Sec Filling | Patents | 796 employees

(US) Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the food and biopharmaceutical industry. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods is able to maximize product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, O Olive Oil & Vinegar® premium artisan products and Yucatan® and Cabo Fresh® avocado products. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market.

msa brands injection

add to watch list email alert is off

Press-releases

Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
Published: 2023-11-20 (Crawled : 21:00) - globenewswire.com
LFCR | $7.07 -1.12% -1.13% 86K

Manufacturing

| -2.69% | O: -0.13% H: 0.94% C: 0.13%
company favorable foods

Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
Published: 2023-10-18 (Crawled : 20:00) - globenewswire.com
LFCR | $7.07 -1.12% -1.13% 86K

Manufacturing

| 2.41% | O: -1.98% H: 8.67% C: 3.03%
nasdaq report

SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement
Published: 2023-10-17 (Crawled : 09:00) - prnewswire.com
LFCR | $7.07 -1.12% -1.13% 86K

Manufacturing

| 2.26% | O: 3.25% H: 5.62% C: 0.27%
partnership medical agreement

Lifecore Biomedical Provides Update for Development Portfolio and Timing of Delayed Filings
Published: 2023-10-10 (Crawled : 20:00) - globenewswire.com
LFCR | $7.07 -1.12% -1.13% 86K

Manufacturing

| -0.82% | O: -0.27% H: 1.93% C: -0.69%
update

Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results
Published: 2023-08-31 (Crawled : 12:00) - globenewswire.com
LFCR | $7.07 -1.12% -1.13% 86K

Manufacturing

| -18.58% | O: -6.64% H: 6.88% C: -3.5%
year results

Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT
Published: 2023-08-22 (Crawled : 20:00) - globenewswire.com
LFCR | $7.07 -1.12% -1.13% 86K

Manufacturing

| Email alert Add to watchlist
conference

Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
Published: 2023-08-22 (Crawled : 20:00) - globenewswire.com
LFCR | $7.07 -1.12% -1.13% 86K

Manufacturing

| Email alert Add to watchlist
nasdaq report

Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
Published: 2023-06-01 (Crawled : 11:00) - globenewswire.com
LFCR | $7.07 -1.12% -1.13% 86K

Manufacturing

| -11.72% | O: 0.12% H: 6.04% C: 0.61%
year results

Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
Published: 2023-05-22 (Crawled : 21:00) - globenewswire.com
LFCR | $7.07 -1.12% -1.13% 86K

Manufacturing

| 34.89% | O: 11.94% H: 58.33% C: 34.17%
ALC | $71.9 -0.04% 0.0% 570K

Health Technology

| -11.8% | O: -0.51% H: 0.02% C: -3.25%
capacity agreement

Lifecore Biomedical Sets Third Quarter 2023 Earnings Conference Call for June 1, 2023 at 7:30 a.m. CT
Published: 2023-05-22 (Crawled : 21:00) - globenewswire.com
LFCR | $7.07 -1.12% -1.13% 86K

Manufacturing

| 34.89% | O: 11.94% H: 58.33% C: 34.17%
conference

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0000921895-23-001426	4	2023-06-05	2023-06-01	Buy	A	18182	28069
0001628280-23-020846	4	2023-06-05	2023-06-01	Buy	A	18182	48519
0001628280-23-020843	4	2023-06-05	2023-06-01	Buy	A	18182	30424